Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Dermatologic 1

Conditions

Multiple Myeloma 2Lymphoma 2Pancreatic Neoplasms 1Melanoma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, B-Cell, Marginal Zone 1Leukemia 1Carcinoma, Non-Small-Cell Lung 1

Interventions

fludarabine phosphate 23Cyclophosphamide 23Peripheral Blood Stem Cell Transplantation 22Antilymphocyte Serum 18Busulfan 16Tacrolimus 15Mycophenolic Acid 15Cyclosporine 14Methotrexate 11Filgrastim 11Whole-Body Irradiation 10Methylprednisolone 9Melphalan 9Sirolimus 6Radiotherapy 6Psychiatric Rehabilitation 6Etoposide 6Cord Blood Stem Cell Transplantation 6sargramostim 4Flow Cytometry 4Early Intervention, Educational 4Polymerase Chain Reaction 3Epoetin Alfa 3Darbepoetin alfa 3Thiotepa 2Therapeutics 2Rituximab 2Ondansetron 2Moxifloxacin 2Morphine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia × Proteasome Inhibitors × Dermatologic × Clear all
NCT00629473 2017-11-22

Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Malignancies

Celgene

Phase 1 Completed
86 enrolled
DermatologicLymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡